Journal article icon

Journal article

Precision medicine in the management of type 2 diabetes

Abstract:

The study of type 2 diabetes has been driven by advances in human genetics, epigenetics, biomarkers, mechanistic studies, and large clinical trials, enabling new insights into disease susceptibility, pathophysiology, progression, and development of complications. Simultaneously, several new drug classes with different mechanisms of action have been introduced over the past two decades, accompanied by data about cardiovascular safety and non-glycaemic outcomes. In this Review, we critically ex...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/S2213-8587(18)30052-4

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
OCDEM
Role:
Author
ORCID:
0000-0003-1205-1844
Publisher:
Elsevier Publisher's website
Journal:
Lancet Diabetes and Endocrinology Journal website
Volume:
6
Issue:
11
Pages:
891-900
Publication date:
2018-04-23
Acceptance date:
2018-04-23
DOI:
ISSN:
2213-8595
Source identifiers:
845670
Pubs id:
pubs:845670
UUID:
uuid:8719ebd4-74ee-48bd-96c0-38de62e42f0a
Local pid:
pubs:845670
Deposit date:
2018-05-02

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP